Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Pugliese

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Diabetes Care|March 18, 2024
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Cell Reports. Medicine|June 5, 2024
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetesGuido Sebastiani, Giuseppina Emanuela Grieco, Marco Bruttini, et al.
Plos One|February 8, 2018
Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humansCharmaine J Simeonovic, Sarah K Popp, Lora M Starrs, et al.
Pediatric Diabetes|December 12, 2013
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findingsAlberto Pugliese, Mingder Yang, Irina Kusmarteva, et al.
Diabetologia|March 17, 2025
Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetesTeresa Rodriguez-Calvo, Jutta E Laiho, Maarit Oikarinen, et al.
JCI Insight|December 13, 2016
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetesHoward R Seay, Erik Yusko, Stephanie J Rothweiler, et al.
Diabetes|December 17, 2016
Differentiation of Diabetes by Pathophysiology, Natural History, and PrognosisJay S Skyler, George L Bakris, Ezio Bonifacio, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Nature Communications|July 1, 2020
Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Diabetes Care|March 18, 2024
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)Lue Ping Zhao, George K Papadopoulos, Jay S Skyler, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Cell Reports. Medicine|June 5, 2024
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetesGuido Sebastiani, Giuseppina Emanuela Grieco, Marco Bruttini, et al.
Plos One|February 8, 2018
Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humansCharmaine J Simeonovic, Sarah K Popp, Lora M Starrs, et al.
Pediatric Diabetes|December 12, 2013
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findingsAlberto Pugliese, Mingder Yang, Irina Kusmarteva, et al.
Diabetologia|March 17, 2025
Enterovirus VP1 protein and HLA class I hyperexpression in pancreatic islet cells of organ donors with type 1 diabetesTeresa Rodriguez-Calvo, Jutta E Laiho, Maarit Oikarinen, et al.
JCI Insight|December 13, 2016
Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetesHoward R Seay, Erik Yusko, Stephanie J Rothweiler, et al.
Diabetes|December 17, 2016
Differentiation of Diabetes by Pathophysiology, Natural History, and PrognosisJay S Skyler, George L Bakris, Ezio Bonifacio, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Nature Communications|July 1, 2020
Long-term culture of human pancreatic slices as a model to study real-time islet regenerationMirza Muhammad Fahd Qadir, Silvia Álvarez-Cubela, Jonathan Weitz, et al.
Pageof 12